{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:41Z","timestamp":1786982201006,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T00:00:00Z","timestamp":1755993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01303-y","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T22:23:57Z","timestamp":1755987837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Shifting and Evolving Neoadjuvant Treatments and Surgical Platforms on Oncological Outcomes and Sphincter Preservation in Distal Rectal Cancer: A 23-Year Retrospective Experience"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-5318","authenticated-orcid":false,"given":"Niyaz","family":"Shadmanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0730-7737","authenticated-orcid":false,"given":"Vusal","family":"Aliyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6587-9787","authenticated-orcid":false,"given":"Bar\u0131s","family":"Bak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6329-0354","authenticated-orcid":false,"given":"Suha","family":"Goksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9147-1654","authenticated-orcid":false,"given":"Oktar","family":"Asoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"issue":"10","key":"1303_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/bjs.1800691019","volume":"69","author":"RJ Heald","year":"1982","unstructured":"Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery\u2013the clue to pelvic recurrence? Br J Surg. 1982Oct;69(10):613\u20136. https:\/\/doi.org\/10.1002\/bjs.1800691019.","journal-title":"Br J Surg"},{"issue":"4","key":"1303_CR2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","volume":"28","author":"RGH Beets-Tan","year":"2018","unstructured":"Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 ESGAR consensus meeting. Eur Radiol. 2018;28(4):1465\u201375.","journal-title":"Eur Radiol"},{"key":"1303_CR3","doi-asserted-by":"publisher","unstructured":"Swedish Rectal Cancer Trial; Cedermark B, Dahlberg M, Glimelius B, P\u00e5hlman L, Rutqvist LE, Wilking N. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997 Apr 3;336(14):980\u20137. https:\/\/doi.org\/10.1056\/NEJM199704033361402. Erratum in: N Engl J Med 1997 May 22;336(21):1539","DOI":"10.1056\/NEJM199704033361402"},{"key":"1303_CR4","doi-asserted-by":"publisher","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001 Aug 30;345(9):638\u201346. https:\/\/doi.org\/10.1056\/NEJMoa010580","DOI":"10.1056\/NEJMoa010580"},{"key":"1303_CR5","doi-asserted-by":"publisher","unstructured":"Sauer R, Becker H, Hohenberger W, R\u00f6del C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004 Oct 21;351(17):1731\u201340. https:\/\/doi.org\/10.1056\/NEJMoa040694","DOI":"10.1056\/NEJMoa040694"},{"issue":"1","key":"1303_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK, Beets-Tan RGH. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus chemoradiotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29\u201342.","journal-title":"Lancet Oncol"},{"key":"1303_CR7","unstructured":"van der Valk, MJM, Marijnen CAM, van Etten B, Dijkstra EA, Kranenbarg EMK, Putter H ... Bahadoer RR (2023) Long-term outcomes of short-course radiotherapy followed by preoperative chemotherapy and total mesorectal excision in locally advanced rectal cancer: results of the RAPIDO trial after 5 years of follow-up. Lancet Oncol. 24(5):463\u2013474."},{"key":"1303_CR8","doi-asserted-by":"crossref","unstructured":"Conroy T, Bosset JF, Etienne PL, Adenis A, Pignon JP, Chapet O ... Fran\u00e7ois E (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for locally advanced rectal cancer (PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 22(5):702\u2013715.","DOI":"10.1016\/S1470-2045(21)00079-6"},{"key":"1303_CR9","unstructured":"Adenis A, Fran\u00e7ois E, Bertaut A, Bosset JF, Pignon JP, Chapet O ... Conroy T (2023) Long-term results of neoadjuvant chemotherapy with FOLFIRINOX and chemoradiotherapy for locally advanced rectal cancer: the PRODIGE 23 phase III trial. Eur J Cancer. 190:111\u2013120."},{"key":"1303_CR10","doi-asserted-by":"publisher","unstructured":"Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM; Timing of Rectal Cancer Response to Chemoradiation Consortium. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011 Jul;254(1):97\u2013102. https:\/\/doi.org\/10.1097\/SLA.0b013e3182196e1f.","DOI":"10.1097\/SLA.0b013e3182196e1f"},{"key":"1303_CR11","doi-asserted-by":"publisher","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K; Timing of Rectal Cancer Response to Chemoradiation Consortium. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol. 2015 Aug;16(8):957\u201366. https:\/\/doi.org\/10.1016\/S1470-2045(15)00004-2.","DOI":"10.1016\/S1470-2045(15)00004-2"},{"key":"1303_CR12","doi-asserted-by":"publisher","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022 Aug 10;40(23):2546\u20132556. https:\/\/doi.org\/10.1200\/JCO.22.00032.","DOI":"10.1200\/JCO.22.00032"},{"key":"1303_CR13","doi-asserted-by":"publisher","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007 Oct 16;4(10):e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","DOI":"10.1371\/journal.pmed.0040296"},{"key":"1303_CR14","doi-asserted-by":"publisher","unstructured":"Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, et al. Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy. J Clin Oncol. 2022 Aug 10;40(23):2546\u20132556. https:\/\/doi.org\/10.1200\/JCO.22.00032.","DOI":"10.1200\/JCO.22.00032"},{"issue":"2","key":"1303_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","volume":"47","author":"R Ryan","year":"2005","unstructured":"Ryan R, Gibbons D, Hyland JM, Treanor D, White A, Mulcahy HE, O\u2019Donoghue DP, Moriarty M, Fennelly D, Sheahan K. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology. 2005;47(2):141\u20136. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02176.x.","journal-title":"Histopathology"},{"issue":"11","key":"1303_CR16","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::aidcncr2820731105>3.0.co;2-c","volume":"73","author":"AM Mandard","year":"1994","unstructured":"Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathol Correl Cancer. 1994;73(11):2680\u20136. https:\/\/doi.org\/10.1002\/1097-0142(19940601)73:11%3c2680::aidcncr2820731105%3e3.0.co;2-c.","journal-title":"Clinicopathol Correl Cancer"},{"key":"1303_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","volume":"373","author":"P Quirke","year":"2009","unstructured":"Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Efect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821\u20138.","journal-title":"Lancet"},{"key":"1303_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10151-005-0226-1","volume":"9","author":"P Hermanek","year":"2005","unstructured":"Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol. 2005;9:193\u2013200. https:\/\/doi.org\/10.1007\/s10151-005-0226-1.","journal-title":"Tech Coloproctol"},{"issue":"3","key":"1303_CR19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.surg.2009.10.012","volume":"147","author":"N Rahbari","year":"2010","unstructured":"Rahbari N, Weitz J, Hohenberger W, Heald R, Moran B, Ulrich A, Holm T, Wong W, Tiret E, Moriya Y, Laurberg S, Dulk D, Van De Velde C, B\u00fcchler M. Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147(3):339\u201351. https:\/\/doi.org\/10.1016\/j.surg.2009.10.012.","journal-title":"Surgery"},{"issue":"19","key":"1303_CR20","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27(19):3109\u201316. https:\/\/doi.org\/10.1200\/JCO.2008.20.6771.","journal-title":"J Clin Oncol"},{"key":"1303_CR21","doi-asserted-by":"crossref","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv22\u2013iv40.","DOI":"10.1093\/annonc\/mdx224"},{"key":"1303_CR22","doi-asserted-by":"publisher","unstructured":"Asoglu O, Tokmak H, Bakir B, Demir G, Ozyar E, et al. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases. Eur J Surg Oncol. 2020 Mar;46(3):402\u2013409. 10.1016\/j.ejso.2019.07.012. Epub 2019 Jul 8. Erratum in: Eur J Surg Oncol. 2020 Sep;46(9):1774. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.042","DOI":"10.1016\/j.ejso.2020.07.042"},{"issue":"16","key":"1303_CR23","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30(16):1926\u201333. https:\/\/doi.org\/10.1200\/JCO.2011.40.1836.","journal-title":"J Clin Oncol"},{"key":"1303_CR24","doi-asserted-by":"crossref","unstructured":"Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C ... Gerard JP (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90\u201301 randomized trial. J Clin Oncol. 17(8):2396\u20132402.","DOI":"10.1200\/JCO.1999.17.8.2396"},{"key":"1303_CR25","doi-asserted-by":"publisher","unstructured":"Glehen O, Chapet O, Adham M, Nemoz JC, Gerard JP; Lyons Oncology Group. Long-term results of the Lyons R90\u201301 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer. Br J Surg. 2003;90(8):996\u20138. https:\/\/doi.org\/10.1002\/bjs.4162.","DOI":"10.1002\/bjs.4162"},{"issue":"1","key":"1303_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12957-022-02816-7s","volume":"20","author":"O Asoglu","year":"2022","unstructured":"Asoglu O, Bulut A, Aliyev V, Piozzi GN, Guven K, Bak\u0131r B, et al. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series. World J Surg Oncol. 2022;20(1):358. https:\/\/doi.org\/10.1186\/s12957-022-02816-7s.","journal-title":"World J Surg Oncol"},{"issue":"16","key":"1303_CR27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1001\/jama.2017.7219","volume":"318","author":"D Jayne","year":"2017","unstructured":"Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, Copeland J, Quirke P, West N, Rautio T, Thomassen N, Tilney H, Gudgeon M, Bianchi PP, Edlin R, Hulme C, Brown J. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR randomized clinical trial. JAMA. 2017Oct 24;318(16):1569\u201380. https:\/\/doi.org\/10.1001\/jama.2017.7219.","journal-title":"JAMA"},{"key":"1303_CR28","doi-asserted-by":"publisher","unstructured":"Corrigan N, Marshall H, Croft J, Copeland J, Jayne D, Brown J. Exploring and adjusting for potential learning effects in ROLARR: a randomised controlled trial comparing robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection. Trials. 2018;19(1):339. https:\/\/doi.org\/10.1186\/s13063-018-2726-0.","DOI":"10.1186\/s13063-018-2726-0"},{"issue":"38","key":"1303_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.52198\/21.STI.38.CR1391","volume":"20","author":"V Aliyev","year":"2021","unstructured":"Aliyev V, Goksel S, Bakir B, Guven K, Asoglu O. Sphincter-saving robotic total mesorectal excision provides better mesorectal specimen and good oncological local control compared with laparoscopic total mesorectal excision in male patients with mid-low rectal cancer. Surg Technol Int. 2021;20(38):160\u20136. https:\/\/doi.org\/10.52198\/21.STI.38.CR1391.","journal-title":"Surg Technol Int"},{"key":"1303_CR30","doi-asserted-by":"publisher","unstructured":"Asoglu O, Kunduz E, Serin KR, I\u015fcan Y, Karanlik H, Bakir B, et al. Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: long-term oncologic outcome in 217 unselected consecutive patients. Surg Laparosc Endosc Percutan Tech. 2014 Apr;24(2):145-52. 10.1097\/SLE.0b013e3182a50e10. Erratum in: Surg Laparosc Endosc Percutan Tech. 2021 Oct 5;31(5):662. https:\/\/doi.org\/10.1097\/SLE.0000000000001002.","DOI":"10.1097\/SLE.0000000000001002"},{"issue":"5","key":"1303_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/SLE.0000000000000664","volume":"29","author":"S Bademler","year":"2019","unstructured":"Bademler S, Koza KB, Ucuncu MZ, Tokmak H, Bakir B, Oral EN, et al. Standardized laparoscopic sphincter-preserving total mesorectal excision for rectal cancer: Median of 10 Years\u2019 long-term oncologic outcome in 217 unselected consecutive patients. Surg Laparosc Endosc Percutan Tech. 2019;29(5):354\u201361. https:\/\/doi.org\/10.1097\/SLE.0000000000000664.","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"issue":"1","key":"1303_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s11701-024-01922-w","volume":"18","author":"N Shadmanov","year":"2024","unstructured":"Shadmanov N, Aliyev V, Piozzi GN, Bak\u0131r B, Goksel S, Asoglu O. Perioperative and long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision: a retrospective study of 672 patients. J Robot Surg. 2024;18(1):144. https:\/\/doi.org\/10.1007\/s11701-024-01922-w.","journal-title":"J Robot Surg"},{"key":"1303_CR33","doi-asserted-by":"publisher","unstructured":"Shadmanov N, Aliyev V, Piozzi GN, Bak\u0131r B, Goksel S, Asoglu O. Is clinical complete response as accurate as pathological complete response in patients with mid-low locally advanced rectal cancer? Ann Coloproctol. 2025 Feb;41(1):57\u201367. https:\/\/doi.org\/10.3393\/ac.2024.00339.0048.","DOI":"10.3393\/ac.2024.00339.0048"},{"issue":"39","key":"1303_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.52198\/21.STI.39.CR1460","volume":"26","author":"V Aliyev","year":"2021","unstructured":"Aliyev V, Goksoy B, Goksel S, Guven K, Bak\u0131r B, Saglam S, Asoglu O. Intersphincteric resection for low rectal cancer: Parameters affecting functional outcomes and survival rates. Surg Technol Int. 2021;26(39):166\u201372. https:\/\/doi.org\/10.52198\/21.STI.39.CR1460.","journal-title":"Surg Technol Int"},{"key":"1303_CR35","doi-asserted-by":"publisher","unstructured":"Aliyev V, Piozzi GN, Bulut A, Guven K, Bakir B, Saglam S, Goksel S, Asoglu O. Robotic vs. laparoscopic intersphincteric resection for low rectal cancer: a case matched study reporting a median of 7-year long-term oncological and functional outcomes. Updates Surg. 2022;74(6):1851\u20131860. https:\/\/doi.org\/10.1007\/s13304-022-01396-1.","DOI":"10.1007\/s13304-022-01396-1"},{"key":"1303_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/jnci\/djw171","volume":"108","author":"M Martens","year":"2016","unstructured":"Martens M, Maas M, Heijnen L, Lambregts D, Leijtens J, Stassen L, Breukink S, Hoff C, Belgers E, Melenhorst J, Jansen R, Buijsen J, Hoofwijk T, Beets-Tan R, Beets G. Long-term outcome of an organ preservation program after neoadjuvant treatment for rectal cancer. J Natl Cancer Inst. 2016;108:12. https:\/\/doi.org\/10.1093\/jnci\/djw171.","journal-title":"J Natl Cancer Inst"},{"key":"1303_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00384-023-04534-2","volume":"38","author":"S Tan","year":"2023","unstructured":"Tan S, Gao Q, Cui Y, Ou Y, Huang S, Feng W. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis. Int J Colorectal Dis. 2023;38:1\u201322. https:\/\/doi.org\/10.1007\/s00384-023-04534-2.","journal-title":"Int J Colorectal Dis"},{"key":"1303_CR38","doi-asserted-by":"publisher","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, Klautke G, Grabenbauer GG, et al. German Rectal Cancer Study Group. Randomized phase II trial of chemoradiotherapy plus \u0131nduction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol. 2019;37(34):3212\u20133222. https:\/\/doi.org\/10.1200\/JCO.19.00308.","DOI":"10.1200\/JCO.19.00308"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01303-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01303-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:31:36Z","timestamp":1757421096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01303-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01303-y","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]},"assertion":[{"value":"16 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent for participation and publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"177"}}